A detailed history of Quent Capital, LLC transactions in Organon & Co. stock. As of the latest transaction made, Quent Capital, LLC holds 878 shares of OGN stock, worth $12,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
878
Previous 795 10.44%
Holding current value
$12,932
Previous $16,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$18.65 - $23.03 $1,547 - $1,911
83 Added 10.44%
878 $16,000
Q2 2024

Jul 08, 2024

SELL
$17.45 - $21.96 $1,204 - $1,515
-69 Reduced 7.99%
795 $16,000
Q1 2024

Jun 28, 2024

SELL
$13.78 - $18.8 $13 - $18
-1 Reduced 0.12%
864 $16,000
Q1 2024

May 02, 2024

SELL
$13.78 - $18.8 $68 - $94
-5 Reduced 0.57%
865 $16,000
Q4 2023

Jun 14, 2024

BUY
$10.95 - $17.32 $4,117 - $6,512
376 Added 76.11%
870 $12,000
Q4 2023

Jan 19, 2024

BUY
$10.95 - $17.32 $4,117 - $6,512
376 Added 76.11%
870 $12,000
Q3 2023

Jun 14, 2024

SELL
$16.59 - $23.77 $4,877 - $6,988
-294 Reduced 37.31%
494 $8,000
Q3 2023

Oct 10, 2023

SELL
$16.59 - $23.77 $4,877 - $6,988
-294 Reduced 37.31%
494 $8,000
Q2 2023

Jun 14, 2024

BUY
$19.27 - $24.63 $19 - $24
1 Added 0.13%
788 $16,000
Q2 2023

Jul 10, 2023

BUY
$19.27 - $24.63 $19 - $24
1 Added 0.13%
788 $16,000
Q1 2023

Jun 14, 2024

SELL
$21.42 - $32.08 $1,670 - $2,502
-78 Reduced 9.02%
787 $18,000
Q1 2023

Apr 05, 2023

BUY
$21.42 - $32.08 $664 - $994
31 Added 4.1%
787 $18,000
Q4 2022

Jan 19, 2023

SELL
$23.31 - $28.61 $16,969 - $20,828
-728 Reduced 49.06%
756 $0
Q3 2022

Nov 10, 2022

BUY
$23.4 - $34.25 $374 - $548
16 Added 1.09%
1,484 $35,000
Q2 2022

Aug 08, 2022

SELL
$31.66 - $38.9 $348 - $427
-11 Reduced 0.74%
1,468 $50,000
Q1 2022

May 12, 2022

SELL
$30.45 - $39.36 $8,891 - $11,493
-292 Reduced 16.49%
1,479 $52,000
Q4 2021

May 12, 2022

BUY
$28.67 - $37.13 $11,209 - $14,517
391 Added 28.33%
1,771 $54,000
Q4 2021

Feb 28, 2022

BUY
$28.67 - $37.13 $39,564 - $51,239
1,380 New
1,380 $42,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.